NEI Research News

A protein shaped like a 'Y' made NEI-funded scientists at Georgia Tech do a double-take may change the way they think about the protein which is sometimes implicated in glaucoma.

NIH scientists have simplified manufacturing and dosing of a potential drug candidate for the autoimmune eye disease uveitis—a vision-threatening condition that accounts for about 15 percent of blindness in the U.S.

A new study by NEI-funded researchers at The Ohio State University suggests that farsighted preschoolers and kindergartners have a harder time paying attention and that could put them at risk of slipping behind in school.

Several studies indicate that the prevalence of myopia is increasing in the U.S. and worldwide, and researchers project that the trend will continue in the coming decades.

A proposal to create a living model of the human retina, the light-sensitive tissue at the back of the eye, won $90,000 in the National Eye Institute (NEI) 3-D Retina Organoid Challenge (3-D ROC).

UW Medicine scientists funded by NEI are discovering how the brain functions when figuring out shapes that are fully seen or partially covered. As the task becomes more difficult, a reasoning and sensory parts of the brain interact through signals.

Researchers at The Rockefeller University have begun to unravel the mystery of how the brain recognizes familiar faces. Their results are published in the journal Science.

Cells within an injured mouse eye can be coaxed into regenerating neurons and those new neurons appear to integrate themselves into the eye’s circuitry, new research shows.

A solar eclipse will be visible across North America for 2 to 3 hours on Monday, August 21, 2017. Watching the moon slowly block out the sun is a rare opportunity but should be attempted with caution.

NEI funded researchers at the University of Illinois at Chicago have identified an enzyme present in the cornea that trigger inflammation during–and even after–a herpes virus infection. Their results are published in the journal Cell Reports.